Capitol Health Limited
(ASX:CAJ) has entered into a Memorandum of Understanding with machine learning company Enlitic LLC.
Under the agreement, Capitol Health will invest up to US$10 million in the Enlitic partnership and will assist to commercialise Enlitic’s deep learning and artificial intelligence protocols in radiology and healthcare.
The medical diagnostic imaging company will gain exclusive use of Enlitic in Australia. The deal also provides for collaboration on international deployment.
Capitol Health told shareholders it expects to commence the project with Enlitic in the first quarter of the 2016 calendar year, with a goal of clinical ready processes for identified afflications by the middle of 2016.
Capitol Health recorded a net profit of $3.86 million at 30 June 2015.
